Tom Hulsey

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Surfactant treatment has become the standard of care in premature infants with respiratory distress syndrome (RDS). Pulmonary hemorrhage, pulmonary edema, pneumonia, and atelectasis have been shown to liberate inflammatory mediators and plasma proteins, which damage type II pneumocytes and inactivate surfactant. These disease processes may, therefore, lead(More)
BACKGROUND Racial differences in carotid intima-media thickness (cIMT) have been suggested to be associated with the disproportionally high prevalence of cardiovascular disease in black adults. The objective of this study was to evaluate the effects of cardiovascular risk factors on the racial differences seen in cIMT in obese children. METHODS Obese(More)
Objective:To evaluate blood gases and ventilatory parameters before and after two doses of surfactant in premature infants with respiratory decompensation after recovery from primary respiratory distress syndrome (RDS).Study Design:This prospective pilot study enrolled infant's ⩾500 g birth weight, from 7 days to 3 months of age, with a secondary(More)
  • 1